In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels

Thrombosis and Haemostasis

Volumn 84, Issue 5, 2000, Pages 904-911

  Westmuckett, A D ^a   Lupu, C ^a   Goulding, D A ^a   Das, S ^a   Kakkar, V V ^a   Lupu, F ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Atherosclerosis; Coagulation; Factor Xa receptor; Immunogold; Thrombin receptor; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; CELL RECEPTOR; HIRUDIN; IMMUNOGLOBULIN G ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR; THROMBOPLASTIN;

ACUTE HEART INFARCTION; ANTIGEN DETECTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION FUNCTION; DISEASE COURSE; EFFECTOR CELL; FIBRIN DEPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGOLD STAINING; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOGENICITY;

EID: 0033678470     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614135     Document Type: Article

References (44)

1. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
2. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina
3. The morphological basis for altered endothelial permeability in atherosclerosis
4. Cytochemical localization of b lipoproteins and their components in succesive stages of hyperlipidemic atherogenesis in rabbit aorta
5. 131I-albumin in the young pig
6. Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits
7. Tissue prothrombin. Universal distribution in smooth muscle
8. Prothrombin-related antigens in human aortic intima
9. Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis: Use of monoclonal antibodies
10. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
11. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels
12. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture
13. Biochemistry and physiology of blood coagulation
14. Identification of active tissue factor in human coronary atheroma
15. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
16. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
17. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries
18. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture
19. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X
20. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding
21. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture
22. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae: Regulatory mechanisms(s) of the anti-coagulant properties of the endothelium
23. Immunoelectrophoretic and immunohistochemical characterization of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudointimas
24. Immunohistochemical study of the intimal microvessels in coronary atherosclerosis
25. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes
26. Identification of effector cell protease receptor-1: A leukocyte-distributed receptor for serine protease factor Xa
27. Human umbilical vein endothelial cells express high affinity receptors for factor Xa
28. Effector protease receptor 1 mediates the mitogenic activity for vascular smooth muscle cells in vitro and in vivo
29. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa
30. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties
31. Co-localization of thrombin, plasminogen activator inhibitor 1 (PAI-1) and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes
32. Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rats
33. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin
34. An endothelial storage granule for tissue-type plasminogen activator
35. Thrombin receptor expression in normal and atherosclerotic human arteries
36. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
37. Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor
38. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions
39. Histopathological study of aorto-coronary bypass grafts with special reference to fibrin deposits on grafted saphenous veins
40. Plasminogen activator expression in human advanced atherosclerotic lesions
41. Fibrin deposition and fibrin degradation products in atherosclerotic plaques
42. Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells
43. The inter-relation of fibrin, lipoprotein(a) and plasminogen in human atherosclerotic lesions
44. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors